26,876 Shares in The Clorox Company $CLX Purchased by Groupe la Francaise

Groupe la Francaise acquired a new stake in The Clorox Company (NYSE:CLX) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 26,876 shares of the company’s stock, valued at approximately $3,213,000.

A number of other hedge funds also recently made changes to their positions in the business. Horizon Investments LLC increased its holdings in shares of Clorox by 4.4% during the 1st quarter. Horizon Investments LLC now owns 1,768 shares of the company’s stock worth $258,000 after acquiring an additional 75 shares during the last quarter. Hancock Whitney Corp boosted its position in Clorox by 4.3% during the first quarter. Hancock Whitney Corp now owns 2,064 shares of the company’s stock worth $304,000 after purchasing an additional 86 shares during the period. Brown Lisle Cummings Inc. increased its holdings in shares of Clorox by 4.3% in the second quarter. Brown Lisle Cummings Inc. now owns 2,136 shares of the company’s stock valued at $256,000 after purchasing an additional 89 shares during the last quarter. American National Bank & Trust increased its holdings in shares of Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after purchasing an additional 89 shares during the last quarter. Finally, Savvy Advisors Inc. raised its position in shares of Clorox by 1.4% in the second quarter. Savvy Advisors Inc. now owns 6,395 shares of the company’s stock valued at $768,000 after purchasing an additional 91 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber bought 4,000 shares of the firm’s stock in a transaction on Friday, November 21st. The shares were purchased at an average cost of $104.13 per share, with a total value of $416,520.00. Following the acquisition, the director directly owned 13,000 shares in the company, valued at $1,353,690. This represents a 44.44% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.63% of the stock is owned by insiders.

Clorox Trading Down 0.7%

Shares of CLX stock opened at $105.12 on Thursday. The stock has a market cap of $12.82 billion, a P/E ratio of 16.50, a price-to-earnings-growth ratio of 0.53 and a beta of 0.57. The Clorox Company has a 1 year low of $98.20 and a 1 year high of $171.37. The company has a current ratio of 0.76, a quick ratio of 0.50 and a debt-to-equity ratio of 18.01. The stock has a 50 day simple moving average of $112.69 and a 200 day simple moving average of $120.64.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.78 by $0.07. The firm had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.41 billion. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The company’s quarterly revenue was down 18.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be given a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, January 28th. This represents a $4.96 annualized dividend and a yield of 4.7%. Clorox’s dividend payout ratio is currently 77.86%.

Analyst Ratings Changes

CLX has been the subject of several research analyst reports. Wells Fargo & Company reduced their target price on shares of Clorox from $125.00 to $117.00 and set an “equal weight” rating for the company in a report on Tuesday, November 4th. Barclays reduced their price objective on Clorox from $112.00 to $108.00 and set an “underweight” rating for the company in a report on Tuesday, November 4th. Jefferies Financial Group reiterated a “buy” rating and set a $152.00 target price on shares of Clorox in a research note on Tuesday, November 4th. Bank of America reduced their price target on Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a research note on Wednesday, October 8th. Finally, UBS Group set a $119.00 price objective on Clorox and gave the company a “neutral” rating in a report on Tuesday, November 4th. One research analyst has rated the stock with a Buy rating, thirteen have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and a consensus price target of $125.69.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.